Navigation Links
Hypogonadism in Medical News

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

... Although testosterone levels decline with age, hypogonadism is not a natural consequence of the aging process. "Men with clinically diagnosed hypogonadism do not need to 'tolerate' the symptoms of low ... by Bayer Schering Pharma AG. ABOUT hypogonadism Hypogonadism, also known as low ...

Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show

... new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone ... at Harvard Medical School . "But treating hypogonadism can result in significant health benefits for ... Morgentaler noted: "Because men who suffer from hypogonadism need to remain on treatment for life, it is very ...

New recommendations by scientific societies about late-onset hypogonadism

... published by Elsevier, will feature new recommendations on late-onset hypogonadism (LOH), recently formulated by major scientific organizations. LOH is a ... symptoms and a deficiency in serum testosterone levels. Late-onset hypogonadism (LOH) is caused by a decline in gonadal production of androgens in males ...

FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus

... to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005. About hypogonadism Male hypogonadism is an increasingly recognized medical condition characterized by a reduced ...

QuatRx Announces Further Positive Phase 3 Results For Ophena(TM) (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...

Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer

... 2004, Dr. Hamdy was a Senior Principal Scientist at Watson Pharmaceuticals where he participated in an ANDA for testosterone gel for the treatment of hypogonadism that was approved 2005. He also participated in multiple INDs in oncology and autoimmune diseases leading to successful phase I and phase II ...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

... markets products to treat overactive bladder, prostate cancer and central precocious puberty and is pursuing regulatory approval of drugs to treat hypogonadism and bladder cancer. Mr. Holveck noted, "In addition to the very successful drug, VANTAS(R), we are particularly excited about the opportunity to ...

JCI online early table of contents: July 1, 2008

... and colleagues, at Massachusetts General Hospital, Boston, has identified mutations in the FGF8 gene in individuals with idiopathic hypogonadotropic hypogonadism (IHH), a disease characterized by failed sexual maturation and infertility due to a deficiency in the small protein gonadotropin-releasing hormone ...

Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men

... Prolonged hypogonadism may result in erectile dysfunction, decreased libido, anemia, sarcopenia, ... level is well-known for its association with osteoporosis, the impact of hypogonadism on overall physical functioning and fall risk has not been prospectively ...
Hypogonadism in Medical Technology

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

... in Europe and other territories. About hypogonadism Male hypogonadism is an increasingly recognized medical condition ... impair quality of life. Common effects of hypogonadism include decreased sexual desire, erectile ...

Indevus Announces Submission of New Drug Application

... reported were comparable to other injectable hypogonadism treatments reported in the literature. There were ... Schering Pharma AG, Germany in July 2005. About hypogonadism Male hypogonadism is an increasingly recognized medical ...

Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome

... 40-69 years, it is estimated that there are about 481,000 new cases of hypogonadism per year. Overall, approximately 2.4 million U.S. men suffer from the condition.(1) hypogonadism results from a deficiency in testosterone secretion that may occur ...

Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association

... previously announced, are based on a Phase III study in which men with hypogonadism and low serum testosterone levels prior to entering the study were treated ... Schering Pharma AG, Germany in July 2005. About Hypogonadism Male hypogonadism is an increasingly recognized medical condition characterized by a reduced ...

QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 as an oral treatment for the symptoms of secondary hypogonadism and other conditions in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. ...

QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...

QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...

Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture

... endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical development. XIAFLEX(TM) (clostridial ...

QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...

More>>

Hypogonadism in Medical Definition

Pathology

... Adrenal insufficiency ( Addison's disease ) - Hypoaldosteronism Gonads Polycystic ovary syndrome - 5-alpha-reductase deficiency - hypogonadism - Delayed puberty - Precocious puberty Other Autoimmune polyendocrine syndrome - Carcinoid syndrome - Laron syndrome - ...
Hypogonadism in Medical Dictionary

Hypogonadism

... Hypogonadotropic hypogonadism Alternative Names: Gonad otropin deficiency ; Kallmann syndrome ; Secondary hypogonadism Prevention : ... Male hypogonadism Types of testosterone therapy Several types of ...

Hypothalamic

... from secondary ( hypothalamic or pituitary) hypogonadism . Autonomic dysfunction may be associated with ... FSH levels may help determine if hypothalamic hypogonadism (low FSH ) or testicular factors (high FSH ) ... alcohol or heavy metals; (2) hypogonadotropic hypogonadism ( congenital or acquired)— idiopathic ...

Testes

... testes . This test is used to differentiate hypogonadism ( ovary or testes ) into primary hypogonadism (problem is with the ovary or testes ) or secondary hypogonadism (problem is with the pituitary gland or the ...

Aplastic anemia

... Glaucoma ( Glaucoma ) Secondary Hyperparathyroidism Secondary hypogonadism (Hypogonadotropic hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , ...

Cryptorchidism

... a deficiency or absence of endogenous testosterone : (1) primary hypogonadism ( congenital or acquired)—testicular failure due to ... ECG . Affected people may have abnormal genitalia ( cryptorchidism ), hypogonadism , or delayed puberty . ^ Top ... At birth , it remains up in the ...

Testosterone

... abnormally low testosterone levels - a medical condition called male hypogonadism . Testosterone should not be used if you are taking the supplement ... SEPA/ testosterone gel In clinical trials for the treatment of male hypogonadism . Combining testosterone gel with the SEPA absorption enhancer allows ...

Anorexia

... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...

Anorexia Nervosa

... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...

Atherosclerosis

... of ED cases. Between 35 and 50 percent of men with diabetes experience ED. Additional features in some cases include hypothyroidism , male hypogonadism , short stature and mild to moderate developmental delay and the complications of type 2 diabetes such as hyperlipidemia (high lipid s) and ...

Atrophy

... vasomotor symptoms associated with menopause , (2) treatment of vulva l and vagina l atrophy , (3) treatment of hypoestrogenism due to hypogonadism , castration , or primary ovarian failure, ... Possible side effects associated with chronic and prolonged use of topical corticosteroids ...

More>>

Hypogonadism in Biological News

Study identifies pathway required for normal reproductive development

... of Medicine. The current study is the latest in a series of investigations by the MGH group into the genetic basis of idiopathic hypogonadotropic hypogonadism (IHH), a rare condition in which puberty does not take place naturally. IHH occurs when a structure in the brain called the hypothalamus fails to ...

New licensing agreement to maximize AIDS drug development

... and South Korea. FortigelTM (testosterone gel), branded Tostrex® outside the United States, is marketed in Sweden for the treatment of male hypogonadism also by ProStrakan. Approvals of Rectogesic and Tostrex by the other member states of the European Union are being sought through the Mutual ...
Hypogonadism in Biological Technology

QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference

... programs. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. QRX-431, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for lipid disorders and obesity. ...
Hypogonadism in Biological Definition

Infertility

... i.e. diabetes mellitus , thyroid disorders Hypothalamic disorders, i.e. Kallmann syndrome Hyperprolactinemia Hypopituitarism hypogonadism due to various causes Psychological factors Drugs, alcohol Testicular factors Genetic causes, e.g. Klinefelter syndrome Neoplasm, ....
Other Contents
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
(Date:10/20/2014)... 2014 JZ Fitness, an independently operated ... wellness programming, authorship, international lecturing and community wellness, created ... the release of the JZ Fitness nutrition app, available ... coaching thousands of individuals on nutrition, Jenn Zerling (“JZ”) ... not require calorie counting or cumbersome food logging. ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Rockynol ... Living Center on Oct. 14. The $11 million project ... services, and a cooked-to-order kitchen with full-service restaurant style ... premier choice for first class Assisted Living apartments,” said ... residents deserve the highest quality of care and this ...
(Date:10/20/2014)... October 20, 2014 Unveiled at the Sept. ... Direction Scorecard conservatively estimates member hospital ROI on membership dues ... dues, The Center provides $12.50 in value to member hospitals. ... Value – Member Dues)/Member Dues. , “This is the ... number and we think the methodology is really sound,” said ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal ... throughout the greater Phoenix area and across Arizona reports ... to catastrophic automobile accidents. Statistics have indicated a steady ... Arizona. As such, Hastings and Hastings has seen a ... those who have been injured through no fault of ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
(Date:10/16/2014)... Institute of Marine Science have received a 3-year, ... identify the streams and wetlands most vulnerable to ... local governments and citizens conserve these important ecosystems. ... of tidal-marsh observations first gathered by VIMS scientists ... can today,s researchers accurately map the slow but ...
(Date:10/16/2014)... Calif. (October 16, 2014) – Post-menopausal women experienced ... on hormone levels or genital bleeding, after 12 ... an investigational fermented soy germ-based nutritional supplement previously ... to a new peer-reviewed pilot study reported in ... (NAMS) annual scientific meeting. , "These data ...
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
Breaking Biology News(10 mins):EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
Other TagsOther Tags